Tag: COVID-19
-
GSK acquires full rights to mRNA candidate vaccines
•
GSK acquires full rights to develop, manufacture and commercialise globally mRNA candidate vaccines for influenza and COVID-19, including…
-
AstraZeneca reports strong growth in 2023 despite COVID-19 challenges
•
AstraZeneca, a global biopharmaceutical company, announced its financial results for the full year 2023, showing a 6% increase…
-
Data shows SARS-CoV-2 human challenge studies safe in healthy young adults
•
Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious…
-
Pakistanis can’t meet life-goals due to ‘Confidence Gap’
•
Standard Chartered latest survey into affluent (comprising emerging affluent, affluent and high net worth) consumers in 12 markets…
-
Spiritus Mundi intends IPO on London Stock Exchange
•
LONDON, UK: Special purpose acquisition vehicle, Spiritus Mundi, intends to launch an initial public offering (IPO) on the…
-
Kingmaker Footwear resumes production at Vietnam factory
•
HONG KONG: Kingmaker Footwear Holdings Limited has resumed production at the group’s factory in Binh Duong Province, Vietnam. Kingmaker Footwear…
-
LNG demand set for growth as global economies recover
•
LONDON: Global liquefied natural gas (LNG) trade increased to 360 million tonnes in 2020, according to Shell’s latest…
-
Property and casualty insurers report 27.5% drop in net income during first nine months of 2020
•
JERSEY CITY: The private U.S. property and casualty (P&C) insurance industry’s net income after taxes dropped 27.5 percent…
-
U.S. FDA approves Gilead’s antiviral Veklury (remdesivir) for treatment of COVID-19
•
FOSTER CITY: Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the…
-
AstraZeneca’s COVID-19 long-acting antibody combination advances into Phase III clinical trials
•
LONDON: AstraZeneca’s long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than…
-
Oncimmune announces UK Government funding for tool for use in COVID-19
•
LONDON: Oncimmune Holdings announced the award of funding from the ‘UK Research and Innovation (UKRI) Ideas to Address…
-
Synairgen and Clinigen sign agreement for treatment of hospitalised patients with COVID-19
•
SOUTHAMPTON: Synairgen plc and Clinigen Group have signed an agreement to launch a Managed Access Program for Synairgen’s…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.